Company Encyclopedia
View More
name
Mirion Tech
MIR.US
Mirion Technologies, Inc. provides radiation detection, measurement, analysis, and monitoring products and services in North America, Europe, and the Asia Pacific. It operates in two segments, Medical, and Nuclear & Safety. The Medical segment offers radiation oncology quality assurance and dosimetry solutions; patient safety solutions for diagnostic imaging and radiation therapy centers; radiation therapy quality assurance solutions for calibrating and verifying imaging and treatment accuracy; and radionuclide therapy products for nuclear medicine applications, such as product handling, medical imaging furniture, and rehabilitation products.
686.01 B
MIR.USMarket value -Rank by Market Cap -/-

Financial Score

05/12/2025 Update
C
Electronic Equipment and InstrumentsIndustry
Industry Ranking34/103
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreC
    • ROE1.58%C
    • Profit Margin2.94%C
    • Gross Margin47.02%B
  • Growth ScoreB
    • Revenue YoY7.81%B
    • Net Profit YoY139.97%A
    • Total Assets YoY31.72%A
    • Net Assets YoY20.13%A
  • Cash ScoreB
    • Cash Flow Margin3404.91%A
    • OCF YoY7.81%B
  • Operating ScoreD
    • Turnover0.29D
  • Debt ScoreC
    • Gearing Ratio45.88%C

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    Strategic Growth and Innovation Drive Buy Rating for Mirion Technologies

    J.P. Morgan analyst Tomohiko Sano maintains a Buy rating on Mirion Technologies due to strategic growth and innovation. The acquisition of Paragon enhances market share in the U.S. and Europe. Investments in AI and digital innovation, along with a strong medical segment, support long-term growth and margin stability. Northland Securities also maintains a Buy rating with a $29.00 price target.

    Tip Ranks·
    US
    MIR
    -1.88%
    Tip Ranks·
    US
    MIR
    -1.88%

    Did a Major Insider Share Sale Just Shift Mirion Technologies' (MIR) Investment Narrative?

    Mirion Technologies director Lawrence D. Kingsley sold 300,000 shares, raising concerns about insider sentiment and future growth plans. Despite this, Mirion's growth catalysts remain unchanged, with a focus on nuclear and medical radiation safety. The sale contrasts with previous share buybacks, highlighting capital allocation challenges. Mirion projects $1.1 billion revenue and $105.2 million earnings by 2028, requiring 7.9% yearly growth. Fair value estimates vary widely, reflecting differing views on acquisition risks and growth potential.

    Simplywall·
    US
    MIR
    -1.88%
    Simplywall·
    US
    MIR
    -1.88%

    Mirion Technologies Completes Acquisition of Paragon Energy Solutions

    Mirion Technologies has completed its acquisition of Paragon Energy Solutions, enhancing its capabilities in the nuclear power industry. This integration combines Paragon's engineering expertise with Mirion's technology portfolio, strengthening its position in the U.S. nuclear market. Paragon will join the Mirion Nuclear & Safety Group, with its solutions present in all North American nuclear reactors. This move is expected to provide comprehensive solutions for both existing and emerging nuclear markets.

    Reuters·
    US
    MIR
    -1.88%
    Reuters·
    US
    MIR
    -1.88%

    Mirion Technologies Director Lawrence D. Kingsley Reports Sale of Common Shares

    Lawrence D. Kingsley, Director of Mirion Technologies Inc., reported the sale of common shares. The original filing is available via EDGAR, the SEC's system. This AI-generated news brief is for informational purposes only and not financial advice. Mirion Technologies is responsible for the original content.

    Reuters·
    US
    MIR
    -1.88%
    Reuters·
    US
    MIR
    -1.88%

    Shareholder Kingsley Lawrence Files To Sell 300,000 Of Mirion TECH Inc [MIR]

    Kingsley Lawrence, a shareholder of Mirion Technologies Inc, filed a Form 144 with the SEC to sell 300,000 restricted shares on November 21, 2025. The sale will be conducted through UBS Financial Services Inc. Filing Form 144 is a prerequisite for selling restricted stock, allowing the owner to sell within 90 days of filing.

    Reuters·
    US
    MIR
    -1.88%
    Reuters·
    US
    MIR
    -1.88%
    © 2025 Longbridge｜Disclaimer